Skip to main content

Uterine Fibroids and Recurrent Pregnancy Loss

  • Chapter
  • First Online:
  • 882 Accesses

Abstract

Fibroids are observed in up to 10.7% of pregnant women and may impact pregnancy outcome. The cumulative risk of sporadic miscarriage when intramural fibroids are noted in the first trimester via ultrasound was estimated to be 20.4%. However, the prevalence of uterine fibroids in women with recurrent pregnancy loss (RPL) is estimated to be only 4.08%. The workup for patients meeting the RPL diagnostic criteria should include genetic karyotype of both parents, endocrine evaluation, uterine assessment with evaluation of the endometrial cavity, and antiphospholipid antibody screening where appropriate. It is generally agreeable that submucous fibroids and intramural fibroids distorting the endometrial cavity should be removed particularly in the context of reproductive complications. On the other side, noncavity-distorting large endometrial fibroid may be associated with sporadic or recurrent pregnancy loss as illustrated in the two cases presented in this chapter. Properly designed studies to evaluate the impact of surgical removal of this subcategory on reproductive outcome are warranted.

This is a preview of subscription content, log in via an institution.

Abbreviations

APH:

Antepartum haemorrhage

APS:

Antiphospholipid syndrome

FDA:

Food and Drug Administration

FSH:

Follicular stimulating hormone

GA:

Gestational age

GDM:

Gestational diabetes mellitus

HSG:

Hysterosalpingogram

MRgFUS:

Magnetic resonance-guided focused ultrasound surgery

MRI:

Magnetic resonance imagine

PPH:

Postpartum hemorrhage

PROM:

Premature rupture of membranes

RCT:

Randomized control trial

RFVTA:

Radiofrequency volumetric thermal ablation

RPL:

Recurrent pregnancy loss

SIS:

Saline infusion sonography

UAE:

Uterine artery embolization

References

  1. Stout MJ, Odibo AO, Graseck AS, Macones GA, Crane JP, Cahill AG. Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes. Obstet Gynecol. 2010;116(5):1056–63.

    Article  PubMed  Google Scholar 

  2. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol. 2009;113(3):630–5.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Russo M, Suen M, Bedaiwy M, Chen I. Prevalence of uterine myomas among women with 2 or more recurrent pregnancy losses: a systematic review. J Minim Invasive Gynecol. 2016;23(5):702–6.

    Article  PubMed  Google Scholar 

  4. Katz VL, Dotters DJ, Droegemeuller W. Complications of uterine leiomyomas in pregnancy. Obstet Gynecol. 1989;73(4):593–6.

    CAS  PubMed  Google Scholar 

  5. Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol. 2000;95(5):764–9.

    CAS  PubMed  Google Scholar 

  6. Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol. 2014;211(4):395.e1–5.

    Article  Google Scholar 

  7. De Carolis S, Fatigante G, Ferrazzani S, Trivellini C, De Santis L, Mancuso S, et al. Uterine myomectomy in pregnant women. Fetal Diagn Ther. 2001;16(2):116–9.

    Article  PubMed  Google Scholar 

  8. Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725–36.

    Article  PubMed  Google Scholar 

  9. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008;198(4):357–66.

    Article  PubMed  Google Scholar 

  10. Buttram VC Jr. Uterine leiomyomata—aetiology, symptomatology and management. Prog Clin Biol Res. 1986;225:275–96.

    PubMed  Google Scholar 

  11. Rice JP, Kay HH, Mahony BS. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol. 1989;160(5 Pt 1):1212–6.

    Article  CAS  PubMed  Google Scholar 

  12. Blum M. Comparative study of serum CAP activity during pregnancy in malformed and normal uterus. J Perinat Med. 1978;6(3):165–8.

    Article  CAS  PubMed  Google Scholar 

  13. Lee HJ, Norwitz ER, Shaw J. Contemporary management of fibroids in pregnancy. Rev Obstet Gynecol. 2010;3(1):20–7.

    PubMed  PubMed Central  Google Scholar 

  14. Kolte AM, Bernardi LA, Christiansen OB, Quenby S, Farquharson RG, Goddijn M, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod (Oxford, England). 2015;30(3):495–8.

    Article  CAS  Google Scholar 

  15. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.

    Article  CAS  PubMed  Google Scholar 

  16. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. Thyroid. 2007;17(11):1159–67.

    Google Scholar 

  17. Jovanovic L, Knopp RH, Kim H, Cefalu WT, Zhu XD, Lee YJ, et al. Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes. Diabetes Care. 2005;28(5):1113–7.

    Article  PubMed  Google Scholar 

  18. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186(3):409–15.

    Article  PubMed  Google Scholar 

  19. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy. Fertil Steril. 2001;76(2):350–7.

    Article  CAS  PubMed  Google Scholar 

  20. Soares SR, Barbosa dos Reis MM, Camargos AF. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril. 2000;73(2):406–11.

    Article  CAS  PubMed  Google Scholar 

  21. Talaulikar VS, Manyonda IT. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids. Adv Ther. 2012;29(8):655–63.

    Article  PubMed  Google Scholar 

  22. Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366(5):409–20.

    Article  CAS  PubMed  Google Scholar 

  23. Donnez J, Tomaszewski J, Vazquez F, Bouchard P, Lemieszczuk B, Baro F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012;366(5):421–32.

    Article  CAS  PubMed  Google Scholar 

  24. Donnez J, Vazquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC, et al. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril. 2014;101(6):1565–73.e1–18.

    Article  CAS  PubMed  Google Scholar 

  25. Luyckx M, Squifflet JL, Jadoul P, Votino R, Dolmans MM, Donnez J. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids. Fertil Steril. 2014;102(5):1404–9.

    Article  CAS  PubMed  Google Scholar 

  26. Monleon J, Martinez-Varea A, Galliano D, Pellicer A. Successful pregnancy after treatment with ulipristal acetate for uterine fibroids. Case Rep Obstet Gynecol. 2014;2014:314587.

    PubMed  PubMed Central  Google Scholar 

  27. Wdowiak A. Commentary on the article “Pre-treatment with ulipristal acetate before ICSI procedure: a case report” published in Menopause Review 6/2013 (Przeglad Menopauzalny 2013; 6: 496-500). Menopause Rev. 2014;13(2):150–1.

    Article  Google Scholar 

  28. Murad K. Spontaneous pregnancy following ulipristal acetate treatment in a woman with a symptomatic uterine fibroid. J Obstet Gynaecol Canada. 2016;38(1):75–9.

    Article  Google Scholar 

  29. Saravelos SH, Yan J, Rehmani H, Li TC. The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage. Hum Reprod. 2011;26(12):3274–9.

    Article  PubMed  Google Scholar 

  30. Bernardi TS, Radosa MP, Weisheit A, Diebolder H, Schneider U, Schleussner E, et al. Laparoscopic myomectomy: a 6-year follow-up single-center cohort analysis of fertility and obstetric outcome measures. Arch Gynecol Obstet. 2014;290(1):87–91.

    Article  PubMed  Google Scholar 

  31. Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev. 2012;(11):CD003857.

    Google Scholar 

  32. Tulandi T, Murray C, Guralnick M. Adhesion formation and reproductive outcome after myomectomy and second-look laparoscopy. Obstet Gynecol. 1993;82(2):213–5.

    CAS  PubMed  Google Scholar 

  33. Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16043.

    Article  PubMed  Google Scholar 

  34. Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S, Bulletti C, et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod. 2000;15(12):2663–8.

    Article  CAS  PubMed  Google Scholar 

  35. Palomba S, Zupi E, Falbo A, Russo T, Marconi D, Tolino A, et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes. Fertil Steril. 2007;88(4):933–41.

    Article  PubMed  Google Scholar 

  36. Lolis DE, Kalantaridou SN, Makrydimas G, Sotiriadis A, Navrozoglou I, Zikopoulos K, et al. Successful myomectomy during pregnancy. Hum Reprod. 2003;18(8):1699–702.

    Article  CAS  PubMed  Google Scholar 

  37. YL M, Wang S, Hao J, Shi M, Yelian FD, Wang XT. Successful pregnancies with uterine leiomyomas and myomectomy at the time of caesarean section. Postgrad Med J. 2011;87(1031):601–4.

    Article  Google Scholar 

  38. Gbadebo AA, Charles AA, Austin O. Myomectomy at caesarean section: descriptive study of clinical outcome in a tropical setting. J Ayub Med Coll Abbottabad. 2009;21(4):7–9.

    PubMed  Google Scholar 

  39. Park BJ, Kim YW. Safety of cesarean myomectomy. J Obstet Gynaecol Res. 2009;35(5):906–11.

    Article  PubMed  Google Scholar 

  40. Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346(8976):671–2.

    Article  CAS  PubMed  Google Scholar 

  41. Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol. 2008;31(1):73–85.

    Article  PubMed  Google Scholar 

  42. Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril. 2010;94(1):324–30.

    Article  PubMed  Google Scholar 

  43. Berkane N, Moutafoff-Borie C. Impact of previous uterine artery embolization on fertility. Curr Opin Obstet Gynecol. 2010;22(3):242–7.

    Article  PubMed  Google Scholar 

  44. Behera MA, Leong M, Johnson L, Brown H. Eligibility and accessibility of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas. Fertil Steril. 2010;94(5):1864–8.

    Article  PubMed  Google Scholar 

  45. Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010;93(1):199–209.

    Article  PubMed  Google Scholar 

  46. Ciavattini A, Tsiroglou D, Litta P, Vichi M, Tranquilli AL. Pregnancy outcome after laparoscopic cryomyolysis of uterine myomas: report of nine cases. J Minim Invasive Gynecol. 2006;13(2):141–4.

    Article  PubMed  Google Scholar 

  47. Vilos GA, Daly LJ, Tse BM. Pregnancy outcome after laparoscopic electromyolysis. J Am Assoc Gynecol Laparosc. 1998;5(3):289–92.

    Article  CAS  PubMed  Google Scholar 

  48. Shen SH, Fennessy F, McDannold N, Jolesz F, Tempany C. Image-guided thermal therapy of uterine fibroids. Semin Ultrasound CT MR. 2009;30(2):91–104.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Berman JM, Bolnick JM, Pemueller RR, Garza Leal JG. Reproductive outcomes in women following radiofrequency volumetric thermal ablation of symptomatic fibroids. A retrospective case series analysis. J Reprod Med. 2015;60(5-6):194–8.

    PubMed  Google Scholar 

  50. Patel A, Malik M, Britten J, Cox J, Catherino WH. Alternative therapies in management of leiomyomas. Fertil Steril. 2014;102(3):649–55.

    Article  PubMed  Google Scholar 

  51. Hald K, Klow NE, Qvigstad E, Istre O. Treatment of uterine myomas with transvaginal uterine artery occlusion: possibilities and limitations. J Minim Invasive Gynecol. 2008;15(5):631–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamed A. Bedaiwy MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Bedaiwy, M.A., Lepik, C., Alfaraj, S. (2018). Uterine Fibroids and Recurrent Pregnancy Loss. In: Moawad, N. (eds) Uterine Fibroids. Springer, Cham. https://doi.org/10.1007/978-3-319-58780-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58780-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-58779-0

  • Online ISBN: 978-3-319-58780-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics